The St. Jude Medical cardiac valve in infants and children: role of anticoagulant therapy

The experience at the University of Colorado with the St. Jude Medical cardiac valve was reviewed to determine the feasibility of placing this prosthesis in children and the role of anticoagulation. A St. Jude Medical cardiac valve was placed in 33 patients ranging in age from 2.5 months to 17 years. Seven patients were less than 1 year of age. Nineteen valves were placed in the aortic position in patients aged 5 months to 17 years (mean 9.5 years). Five patients had valve replacement only, 13 had concomitant aortoventriculoplasty and 1 a Manouguian procedure. Indications for anulus enlarging procedures were recurrent subaortic stenosis or inability to place an adult-sized valve in the native aortic anulus, or both. There were no early or late deaths. Fourteen valves were placed in the mitral position. They were anular positioned in 6 patients aged 6 months to 16 years and supraanular positioned in 8 patients aged 2.5 months to 2 years. There were no deaths with the anular positioned replacements and seven deaths (two early and five late) with the supraanular positioned replacements. Four of the five late deaths were associated with marked pre- and postoperative left ventricular dysfunction. The follow-up time was 784 patient-months in 31 long-term survivors. Anticoagulation was achieved with warfarin, usually in combination with sulfinpyrazone, dipyridamole or aspirin. There were four episodes of thromboembolism, three occurring in patients with suboptimal anticoagulation, and one in a patient lost to follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. C. Sung, Y. H. Chang, H. D. Lee, and J. S. Woo A Novel Technique of Supra-Annular Mitral Valve Replacement Ann. Thorac. Surg., September 1, 2008; 86(3): 1033 - 1035. [Abstract] [Full Text] [PDF]

				P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]

				H. A. Vohra, S. Laker, O. Stumper, J. V. De Giovanni, J. G. Wright, D. J. Barron, and W. J. Brawn Predicting the performance of mitral prostheses implanted in children under 5 years of age. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 688 - 692. [Abstract] [Full Text] [PDF]

				P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 645S - 687S. [Abstract] [Full Text] [PDF]

				M. Masuda, H. Kado, H. Tatewaki, Y. Shiokawa, and H. Yasui Late results after mitral valve replacement with bileaflet mechanical prosthesis in children: evaluation of prosthesis-patient mismatch Ann. Thorac. Surg., March 1, 2004; 77(3): 913 - 917. [Abstract] [Full Text] [PDF]

				C. Alexiou, M. Galogavrou, Q. Chen, A. McDonald, A. P. Salmon, B. K. Keeton, M. P. Haw, and J. L. Monro Mitral valve replacement with mechanical prostheses in children: improved operative risk and survival Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 105 - 113. [Abstract] [Full Text] [PDF]

				P. Monagle, A. D. Michelson, E. Bovill, and M. Andrew Antithrombotic Therapy in Children Chest, January 1, 2001; 119(1_suppl): 344S - 370S. [Full Text] [PDF]

				C van Doorn, R Yates, V Tsang, M deLeval, and M Elliott Mitral valve replacement in children: mortality, morbidity, and haemodynamic status up to medium term follow up Heart, December 1, 2000; 84(6): 636 - 642. [Abstract] [Full Text]

				T. Gunther, D. Mazzitelli, C. Schreiber, M. Wottke, S.-U. Paek, H. Meisner, and R. Lange Mitral-valve replacement in children under 6 years of age Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 426 - 430. [Abstract] [Full Text] [PDF]

				U. S. Krishnan, W. M. Gersony, E. Berman-Rosenzweig, and H. D. Apfel Late Left Ventricular Function After Surgery for Children With Chronic Symptomatic Mitral Regurgitation Circulation, December 16, 1997; 96(12): 4280 - 4285. [Abstract] [Full Text]

				S. M. Bradley, R. M. Sade, F. A. Crawford Jr, and M. R. Stroud Anticoagulation in Children With Mechanical Valve Prostheses Ann. Thorac. Surg., July 1, 1997; 64(1): 30 - 34. [Abstract] [Full Text]

				F. M. Lupinetti, J. Warner, T. K. Jones, and S. P. Herndon Comparison of Human Tissues and Mechanical Prostheses for Aortic Valve Replacement in Children Circulation, July 1, 1997; 96(1): 321 - 325. [Abstract] [Full Text]

				M. Ibrahim, J. Cleland, H. O'Kane, D. Gladstone, C. Mullholland, and B. Craig St. Jude Medical prosthesis in children J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 52 - 56. [Abstract] [Full Text]

				J. A. Smith, K. Desai, D. Bernstein, and B. A. Reitz Successful thrombolysis of a thrombosed St. Jude Medical mitral prosthesis in a two-month-old infant J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 187 - 188. [Full Text]